MT-ND6 - mitochondrially encoded NADH dehydrogenase 6 Gene
Also Known as MTND6; ND6
Species: Homo sapiens
Summary
Enables NADH dehydrogenase (ubiquinone) activity. Involved in mitochondrial electron transport, NADH to ubiquinone and mitochondrial respiratory chain complex I assembly. Predicted to be located in mitochondrial inner membrane. Implicated in Leber hereditary optic neuropathy; Leigh disease; and spinal muscular atrophy with lower extremity predominante 2B. [provided by Alliance of Genome Resources, Apr 2022]
MT-ND6 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| YP_003024037.1 NADH dehydrogenase subunit 6 (mitochondrion) [Homo sapiens] |
| Molecular Function GO Annotation | Evidence | References | Source |
|---|---|---|---|
| enables NADH dehydrogenase (ubiquinone) activity |
IMP
IMP: Inferred from mutant phenotype
|
8644732 | GOA |
| Biological Process GO Annotation | Evidence | References | Source |
|---|---|---|---|
| involved in mitochondrial electron transport, NADH to ubiquinone |
IMP
IMP: Inferred from mutant phenotype
|
8644732 | GOA |
| involved in mitochondrial respiratory chain complex I assembly |
IMP
IMP: Inferred from mutant phenotype
|
14595656 | GOA |
| Cellular Component GO Annotation | Evidence | References | Source |
|---|---|---|---|
| located in mitochondrial inner membrane |
IDA
IDA: Inferred from direct assay
|
28844695 | GOA |
MT-ND6 Protein Structure
Oxidored_q3: NADH-ubiquinone/plastoquinone oxidoreductase chain 6 (15 - 171)
- 0
- 100
- 174 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
NADH dehydrogenase subunit 6 |
|
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Leber Hereditary Optic Neuropathy, Modifier Of |
|
|
| Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, And Stroke-Like Episodes |
|
|
| Leber Optic Atrophy And Dystonia |
|
|
| Oncocytoma |
|
|
| Leigh Syndrome |
|
|
| Leber Plus Disease |
|
|
| Mitochondrial Disease |
|
|
| Mitochondrial Dna-Associated Leigh Syndrome |
|
|
| Hereditary Optic Neuropathy |
|
|
| Parkinsonism |
|
|
| Parkinson Disease 6, Autosomal Recessive Early-Onset |
|
|
| Dystonia |
|
|
| Kearns-Sayre Syndrome |
|
|
| Neuropathy |
|
|
| Mitochondrial Encephalomyopathy |
|
|
| Optic Nerve Disease |
|
|
| Mitochondrial Complex Iv Deficiency, Nuclear Type 5 |
|
|
| Cortical Blindness |
|
|
| Thelaziasis |
|
|
| Congenital Nystagmus 1 |
|
|
| Cranial Nerve Disease |
|
|
| Fasciolopsiasis |
|
|
| Optic Neuritis |
|
|
| Lactic Acidosis |
|
|
| Scotoma |
|
|
| Optic Atrophy 7 With Or Without Auditory Neuropathy |
|
|
| 3-Methylglutaconic Aciduria, Type Iii |
|
|
| Nutritional Optic Neuropathy |
|
|
| Mitochondrial Metabolism Disease |
|
|
| Neuropathy, Ataxia, And Retinitis Pigmentosa |
|
|
| Toxic Optic Neuropathy |
|
|
| Deafness, Aminoglycoside-Induced |
|
|
| Parathyroid Oncocytic Adenoma |
|
|
| Chronic Progressive External Ophthalmoplegia |
|
|
| Pearson Marrow-Pancreas Syndrome |
|
|
| Pseudopapilledema |
|
|
| Mitochondrial Complex I Deficiency, Nuclear Type 16 |
|
|
| Mitochondrial Complex I Deficiency, Nuclear Type 1 |
|
|
| Mitochondrial Myopathy |
|
|
| Myoclonic Epilepsy Associated With Ragged-Red Fibers |
|
|
| Cardiomyopathy, Infantile Hypertrophic |
|
|
| Neonatal Period Electroclinical Syndrome |
|
|
| Early Myoclonic Encephalopathy |
|
|
| Spinal Muscular Atrophy |
|
|
| Mitochondrial Dna Depletion Syndrome |
|
|
| Peripheral Nervous System Disease |
|
|
| Retinitis Pigmentosa |
|
|